245 related articles for article (PubMed ID: 16575849)
1. The complex nature of the interaction between disease activity and therapy on the lipid profile in patients with pediatric systemic lupus erythematosus.
Sarkissian T; Beyenne J; Feldman B; Adeli K; Silverman E
Arthritis Rheum; 2006 Apr; 54(4):1283-90. PubMed ID: 16575849
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal examination of lipid profiles in pediatric systemic lupus erythematosus.
Sarkissian T; Beyene J; Feldman B; McCrindle B; Silverman ED
Arthritis Rheum; 2007 Feb; 56(2):631-8. PubMed ID: 17265498
[TBL] [Abstract][Full Text] [Related]
3. High insulin levels and increased low-density lipoprotein oxidizability in pediatric patients with systemic lupus erythematosus.
Posadas-Romero C; Torres-Tamayo M; Zamora-González J; Aguilar-Herrera BE; Posadas-Sánchez R; Cardoso-Saldaña G; Ladrón de Guevara G; Solis-Vallejo E; El Hafidi M
Arthritis Rheum; 2004 Jan; 50(1):160-5. PubMed ID: 14730612
[TBL] [Abstract][Full Text] [Related]
4. Predictors of lipid abnormalities in children with new-onset systemic lupus erythematosus.
Tyrrell PN; Beyene J; Benseler SM; Sarkissian T; Silverman ED
J Rheumatol; 2007 Oct; 34(10):2112-9. PubMed ID: 17787042
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory mechanisms affecting the lipid profile in patients with systemic lupus erythematosus.
Chung CP; Oeser A; Solus J; Avalos I; Gebretsadik T; Shintani A; Linton MF; Fazio S; Stein CM
J Rheumatol; 2007 Sep; 34(9):1849-54. PubMed ID: 17659756
[TBL] [Abstract][Full Text] [Related]
6. Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?
Karp I; Abrahamowicz M; Fortin PR; Pilote L; Neville C; Pineau CA; Esdaile JM
Arthritis Rheum; 2008 Feb; 59(2):169-75. PubMed ID: 18240259
[TBL] [Abstract][Full Text] [Related]
7. Longterm beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy.
Borba EF; Bonfá E
J Rheumatol; 2001 Apr; 28(4):780-5. PubMed ID: 11327250
[TBL] [Abstract][Full Text] [Related]
8. Changes in lipid profile between flare and remission of patients with systemic lupus erythematosus: a prospective study.
Urquizu-Padilla M; Balada E; Chacon P; Pérez EH; Vilardell-Tarrés M; Ordi-Ros J
J Rheumatol; 2009 Aug; 36(8):1639-45. PubMed ID: 19531751
[TBL] [Abstract][Full Text] [Related]
9. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
Svenungsson E; Gunnarsson I; Fei GZ; Lundberg IE; Klareskog L; Frostegård J
Arthritis Rheum; 2003 Sep; 48(9):2533-40. PubMed ID: 13130473
[TBL] [Abstract][Full Text] [Related]
10. Lipid profiles in patients with systemic lupus erythematosus.
Leong KH; Koh ET; Feng PH; Boey ML
J Rheumatol; 1994 Jul; 21(7):1264-7. PubMed ID: 7966068
[TBL] [Abstract][Full Text] [Related]
11. Dietary treatment of hyperlipidemia in patients with systemic lupus erythematosus.
Hearth-Holmes M; Baethge BA; Broadwell L; Wolf RE
J Rheumatol; 1995 Mar; 22(3):450-4. PubMed ID: 7783060
[TBL] [Abstract][Full Text] [Related]
12. Effects of dietary modification and fish oil supplementation on dyslipoproteinemia in pediatric systemic lupus erythematosus.
Ilowite NT; Copperman N; Leicht T; Kwong T; Jacobson MS
J Rheumatol; 1995 Jul; 22(7):1347-51. PubMed ID: 7562770
[TBL] [Abstract][Full Text] [Related]
13. Management of dyslipidemia in children and adolescents with systemic lupus erythematosus.
Ardoin SP; Sandborg C; Schanberg LE
Lupus; 2007; 16(8):618-26. PubMed ID: 17711898
[TBL] [Abstract][Full Text] [Related]
14. Serum lipoprotein(a) level and its clinical significance in patients with systemic lupus erythematosus.
Sari RA; Polat MF; Taysi S; Bakan E; Capoğlu I
Clin Rheumatol; 2002 Nov; 21(6):520-4. PubMed ID: 12447639
[TBL] [Abstract][Full Text] [Related]
15. High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy.
García-Gómez C; Nolla JM; Valverde J; Narváez J; Corbella E; Pintó X
Eur J Clin Invest; 2008 Sep; 38(9):686-92. PubMed ID: 18837746
[TBL] [Abstract][Full Text] [Related]
16. [The lipid-protein indices of the blood cholesterol transport system in systemic lupus erythematosus].
Alekberova ZS; Popkova TV; Nasonov EL; Reshetniak TM; Ozerova IN; Perova NV
Ter Arkh; 1999; 71(5):34-8. PubMed ID: 10399228
[TBL] [Abstract][Full Text] [Related]
17. Chylomicron metabolism is markedly altered in systemic lupus erythematosus.
Borba EF; Bonfá E; Vinagre CG; Ramires JA; Maranhão RC
Arthritis Rheum; 2000 May; 43(5):1033-40. PubMed ID: 10817556
[TBL] [Abstract][Full Text] [Related]
18. The lipid, lipoprotein, and apolipoprotein effects of hydroxychloroquine in patients with systemic lupus erythematosus.
Hodis HN; Quismorio FP; Wickham E; Blankenhorn DH
J Rheumatol; 1993 Apr; 20(4):661-5. PubMed ID: 8496861
[TBL] [Abstract][Full Text] [Related]
19. Lipid profiles in pediatric thoracic transplant recipients are determined by their immunosuppressive regimens.
Law YM; Yim R; Agatisa P; Boyle GJ; Miller SA; Lawrence K; Webber SA
J Heart Lung Transplant; 2006 Mar; 25(3):276-82. PubMed ID: 16507419
[TBL] [Abstract][Full Text] [Related]
20. Sequential analysis of the lipid profile of children post-renal transplantation.
Singh A; Tejani C; Benfield M; Tejani A
Pediatr Transplant; 1998 Aug; 2(3):216-23. PubMed ID: 10084746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
